NO312495B1 - Lipofile b¶rerpreparat, anvendelse derav som b¶rer, samt farmasöytisk blanding omfattende lipofilt b¶rerpreparat oganvendelse av et galaktolipidmateriale for fremstilling av etlipofilt b¶rerpreparat, og omvendte vesikler - Google Patents

Lipofile b¶rerpreparat, anvendelse derav som b¶rer, samt farmasöytisk blanding omfattende lipofilt b¶rerpreparat oganvendelse av et galaktolipidmateriale for fremstilling av etlipofilt b¶rerpreparat, og omvendte vesikler Download PDF

Info

Publication number: NO312495B1
Authority: NO; Norway
Prior art keywords: polar; lipid; lipophilic carrier; oil; galactolipid material
Prior art date: 1994-02-04

Application number

NO19963242A

Other languages

English (en)

Norwegian (no)

Other versions

NO963242L (no

NO963242D0 (no

Inventor

Anders Carlsson

Bengt Hersloef

Original Assignee

Lipocore Holding Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-04

Filing date

1996-08-02

Publication date

2002-05-21

1994-02-04 Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx

1994-07-12 Priority claimed from SE9402456A external-priority patent/SE517678C2/sv

1996-08-02 Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab

1996-08-02 Publication of NO963242L publication Critical patent/NO963242L/no

1996-08-02 Publication of NO963242D0 publication Critical patent/NO963242D0/no

2002-05-21 Publication of NO312495B1 publication Critical patent/NO312495B1/no

Links

238000002360 preparation method Methods 0.000 title claims description 51
239000000463 material Substances 0.000 title claims description 48
239000008194 pharmaceutical composition Substances 0.000 title description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 title 1
239000005977 Ethylene Substances 0.000 title 1
150000002632 lipids Chemical class 0.000 claims description 63
239000000203 mixture Substances 0.000 claims description 43
239000003921 oil Substances 0.000 claims description 41
235000019198 oils Nutrition 0.000 claims description 34
150000003904 phospholipids Chemical class 0.000 claims description 13
239000002537 cosmetic Substances 0.000 claims description 11
239000000126 substance Substances 0.000 claims description 11
239000000839 emulsion Substances 0.000 claims description 10
230000000975 bioactive effect Effects 0.000 claims description 8
239000000693 micelle Substances 0.000 claims description 8
235000019482 Palm oil Nutrition 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 7
239000002540 palm oil Substances 0.000 claims description 7
239000013543 active substance Substances 0.000 claims description 6
239000007864 aqueous solution Substances 0.000 claims description 6
DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 6
235000008524 evening primrose extract Nutrition 0.000 claims description 4
239000010475 evening primrose oil Substances 0.000 claims description 4
229940089020 evening primrose oil Drugs 0.000 claims description 4
239000002798 polar solvent Substances 0.000 claims description 3
235000013305 food Nutrition 0.000 claims description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
239000004615 ingredient Substances 0.000 description 13
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
229940079593 drug Drugs 0.000 description 12
239000003814 drug Substances 0.000 description 12
KDYAPQVYJXUQNY-OPHDRXFHSA-N 1,2-di-(alpha-linolenoyl)-3-[alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KDYAPQVYJXUQNY-OPHDRXFHSA-N 0.000 description 11
239000000243 solution Substances 0.000 description 11
-1 sterol esters Chemical class 0.000 description 11
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
239000006185 dispersion Substances 0.000 description 10
239000012071 phase Substances 0.000 description 10
239000000499 gel Substances 0.000 description 9
235000007319 Avena orientalis Nutrition 0.000 description 8
244000075850 Avena orientalis Species 0.000 description 8
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 8
AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 8
238000009472 formulation Methods 0.000 description 8
241000196324 Embryophyta Species 0.000 description 7
239000004530 micro-emulsion Substances 0.000 description 7
241000209140 Triticum Species 0.000 description 6
235000021307 Triticum Nutrition 0.000 description 6
150000004665 fatty acids Chemical group 0.000 description 6
238000002156 mixing Methods 0.000 description 6
239000002245 particle Substances 0.000 description 6
239000002253 acid Substances 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
239000000969 carrier Substances 0.000 description 5
235000013339 cereals Nutrition 0.000 description 5
235000014113 dietary fatty acids Nutrition 0.000 description 5
239000000194 fatty acid Substances 0.000 description 5
229930195729 fatty acid Natural products 0.000 description 5
229930182830 galactose Natural products 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
239000000047 product Substances 0.000 description 5
150000003626 triacylglycerols Chemical class 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
108010036949 Cyclosporine Proteins 0.000 description 4
229930186217 Glycolipid Natural products 0.000 description 4
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
235000007238 Secale cereale Nutrition 0.000 description 4
244000082988 Secale cereale Species 0.000 description 4
229930182558 Sterol Natural products 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
229960001265 ciclosporin Drugs 0.000 description 4
229960002563 disulfiram Drugs 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
239000007788 liquid Substances 0.000 description 4
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
239000002904 solvent Substances 0.000 description 4
235000003702 sterols Nutrition 0.000 description 4
239000000725 suspension Substances 0.000 description 4
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
239000007762 w/o emulsion Substances 0.000 description 4
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
108010068370 Glutens Proteins 0.000 description 3
NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
150000001720 carbohydrates Chemical group 0.000 description 3
238000001816 cooling Methods 0.000 description 3
JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 3
239000007789 gas Substances 0.000 description 3
238000004817 gas chromatography Methods 0.000 description 3
239000008103 glucose Substances 0.000 description 3
235000021312 gluten Nutrition 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
238000005984 hydrogenation reaction Methods 0.000 description 3
230000003993 interaction Effects 0.000 description 3
239000000787 lecithin Substances 0.000 description 3
235000010445 lecithin Nutrition 0.000 description 3
229940067606 lecithin Drugs 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
238000000034 method Methods 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
150000004671 saturated fatty acids Chemical class 0.000 description 3
239000000741 silica gel Substances 0.000 description 3
229910002027 silica gel Inorganic materials 0.000 description 3
239000000377 silicon dioxide Substances 0.000 description 3
239000002002 slurry Substances 0.000 description 3
125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 3
239000002562 thickening agent Substances 0.000 description 3
235000015112 vegetable and seed oil Nutrition 0.000 description 3
239000008158 vegetable oil Substances 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
239000004215 Carbon black (E152) Substances 0.000 description 2
229930105110 Cyclosporin A Natural products 0.000 description 2
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
235000010469 Glycine max Nutrition 0.000 description 2
241000282412 Homo Species 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
239000000679 carrageenan Substances 0.000 description 2
235000010418 carrageenan Nutrition 0.000 description 2
229920001525 carrageenan Polymers 0.000 description 2
229940113118 carrageenan Drugs 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000006071 cream Substances 0.000 description 2
229930182912 cyclosporin Natural products 0.000 description 2
OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
150000002149 estolides Chemical class 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
238000000605 extraction Methods 0.000 description 2
150000002191 fatty alcohols Chemical class 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000005556 hormone Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
150000001261 hydroxy acids Chemical class 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
239000010410 layer Substances 0.000 description 2
235000013310 margarine Nutrition 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
150000002772 monosaccharides Chemical group 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000002674 ointment Substances 0.000 description 2
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
150000003905 phosphatidylinositols Chemical class 0.000 description 2
239000011148 porous material Substances 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
239000011877 solvent mixture Substances 0.000 description 2
239000008347 soybean phospholipid Substances 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
238000005809 transesterification reaction Methods 0.000 description 2
125000005314 unsaturated fatty acid group Chemical group 0.000 description 2
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
239000005695 Ammonium acetate Substances 0.000 description 1
102000055006 Calcitonin Human genes 0.000 description 1
108060001064 Calcitonin Proteins 0.000 description 1
241000156978 Erebia Species 0.000 description 1
229920000896 Ethulose Polymers 0.000 description 1
239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
244000000231 Sesamum indicum Species 0.000 description 1
235000003434 Sesamum indicum Nutrition 0.000 description 1
244000062793 Sorghum vulgare Species 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
QZXMUPATKGLZAP-DXLAUQRQSA-N [(2S)-1-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QZXMUPATKGLZAP-DXLAUQRQSA-N 0.000 description 1
ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000011149 active material Substances 0.000 description 1
208000029650 alcohol withdrawal Diseases 0.000 description 1
150000001335 aliphatic alkanes Chemical class 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
235000020661 alpha-linolenic acid Nutrition 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
235000019257 ammonium acetate Nutrition 0.000 description 1
229940043376 ammonium acetate Drugs 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000001741 anti-phlogistic effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000003908 antipruritic agent Substances 0.000 description 1
229940064004 antiseptic throat preparations Drugs 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000003212 astringent agent Substances 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
229960004015 calcitonin Drugs 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000012159 carrier gas Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
150000001840 cholesterol esters Chemical class 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012937 correction Methods 0.000 description 1
239000008271 cosmetic emulsion Substances 0.000 description 1
239000008406 cosmetic ingredient Substances 0.000 description 1
238000013480 data collection Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
239000008344 egg yolk phospholipid Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
238000000105 evaporative light scattering detection Methods 0.000 description 1
235000019387 fatty acid methyl ester Nutrition 0.000 description 1
125000001924 fatty-acyl group Chemical group 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
229940124563 hair growth stimulant Drugs 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
239000007970 homogeneous dispersion Substances 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000010354 integration Effects 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
235000020778 linoleic acid Nutrition 0.000 description 1
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
229960004488 linolenic acid Drugs 0.000 description 1
KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
238000003760 magnetic stirring Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
235000019713 millet Nutrition 0.000 description 1
FIJGNIAJTZSERN-DQQGJSMTSA-N monogalactosyl-diacylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O FIJGNIAJTZSERN-DQQGJSMTSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000007764 o/w emulsion Substances 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
239000002304 perfume Substances 0.000 description 1
150000008105 phosphatidylcholines Chemical class 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
229940001470 psychoactive drug Drugs 0.000 description 1
239000004089 psychotropic agent Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
235000003441 saturated fatty acids Nutrition 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
150000003408 sphingolipids Chemical class 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
150000003432 sterols Chemical class 0.000 description 1
238000003860 storage Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000002377 thylakoid Anatomy 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Food Science & Technology (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Birds (AREA)
Polymers & Plastics (AREA)
Biophysics (AREA)
Nutrition Science (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
General Preparation And Processing Of Foods (AREA)
Cosmetics (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

NO19963242A 1994-02-04 1996-08-02 Lipofile b¶rerpreparat, anvendelse derav som b¶rer, samt farmasöytisk blanding omfattende lipofilt b¶rerpreparat oganvendelse av et galaktolipidmateriale for fremstilling av etlipofilt b¶rerpreparat, og omvendte vesikler NO312495B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9400368A SE9400368D0 (sv)	1994-02-04	1994-02-04	Glycolipid material
SE9402456A SE517678C2 (sv)	1994-07-12	1994-07-12	Lipofila bärarpreparat med en kontinuerlig lipidfas
PCT/SE1995/000117 WO1995020945A1 (en)	1994-02-04	1995-02-06	Lipophilic carrier preparations

Publications (3)

Publication Number	Publication Date
NO963242L NO963242L (no)	1996-08-02
NO963242D0 NO963242D0 (no)	1996-08-02
NO312495B1 true NO312495B1 (no)	2002-05-21

Family

ID=26661956

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19963242A NO312495B1 (no)	1994-02-04	1996-08-02	Lipofile b¶rerpreparat, anvendelse derav som b¶rer, samt farmasöytisk blanding omfattende lipofilt b¶rerpreparat oganvendelse av et galaktolipidmateriale for fremstilling av etlipofilt b¶rerpreparat, og omvendte vesikler

Country Status (19)

Country	Link
US (1)	US5716639A (pl)
EP (1)	EP0743851B1 (pl)
JP (1)	JP3203359B2 (pl)
KR (1)	KR100220546B1 (pl)
CN (1)	CN1091591C (pl)
AT (1)	ATE201980T1 (pl)
AU (1)	AU691250B2 (pl)
CA (1)	CA2182577C (pl)
DE (1)	DE69521300T2 (pl)
DK (1)	DK0743851T3 (pl)
ES (1)	ES2158084T3 (pl)
FI (1)	FI963066A (pl)
HU (1)	HU221432B (pl)
MY (1)	MY112435A (pl)
NO (1)	NO312495B1 (pl)
NZ (1)	NZ279954A (pl)
PL (1)	PL178394B1 (pl)
TW (1)	TW482685B (pl)
WO (1)	WO1995020945A1 (pl)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9403855D0 (en) *	1994-03-01	1994-04-20	Scotia Holdings Plc	Fatty acid derivatives
EA001326B1 (ru) *	1996-05-10	2001-02-26	Унилевер Н.В.	Композиция, содержащая жидкий жирный компонент
EA001116B1 (ru) *	1996-05-10	2000-10-30	Яманоути Юроп Б.В.	Быстрорастворимый везикулярный продукт
GR1002706B (el) *	1996-05-22	1997-05-26		Μικρογαλακτωματα λεκιθινης περιεχοντα πρωτεολυτικα ενζυμα α-χυμοθρυψινης η θρυψινη και μεθοδος μονιμης ενζυμικης αποτριχωσης.
DE19645657A1 (de) *	1996-11-06	1998-05-28	Rhone Poulenc Rorer Gmbh	Phospholipidische Zusammensetzung, Verfahren zur Herstellung einer derartigen Zusammensetzung und Verwendung derselben
SE9702630D0 (sv) *	1997-07-07	1997-07-07	Scotia Lipidteknik Ab	Satiety product
US6017545A (en) *	1998-02-10	2000-01-25	Modi; Pankaj	Mixed micellar delivery system and method of preparation
US6221378B1 (en)	1998-02-10	2001-04-24	Generex Pharmaceuticals Incorporated	Mixed micellar delivery system and method of preparation
US7070799B1 (en) *	1998-02-10	2006-07-04	Generex Pharmaceuticals, Inc.	Method for administering insulin to the buccal region
DE19819273A1 (de) *	1998-04-30	1999-11-11	Pharmatec International S Giul	Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
SE9804192D0 (sv) *	1998-12-03	1998-12-03	Scotia Lipidteknik Ab	New formulation
EP1043016B1 (en) *	1999-03-30	2014-08-20	Sodic Sa	A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
US6916488B1 (en) *	1999-11-05	2005-07-12	Biocure, Inc.	Amphiphilic polymeric vesicles
SE0000730D0 (sv) *	2000-03-06	2000-03-06	Scotia Holdings Plc	Lipid carrier
DE10019171A1 (de) *	2000-04-07	2001-10-18	Schering Ag	Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
EP1151745A1 (fr) *	2000-05-05	2001-11-07	L'oreal	Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
WO2003035112A1 (fr) *	2001-10-22	2003-05-01	Jiro Kanie	Nutriant enteral et procede de production de celui-ci
US20030113366A1 (en) *	2001-12-14	2003-06-19	Macgregor Alexander	Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
SE0200475D0 (sv) *	2002-02-15	2002-02-15	Ltp Lipid Technologies Provide	Oral farmaceutisk beredning
SE0201922D0 (sv) *	2002-06-20	2002-06-20	Ltp Lipid Technologies Provide	Koagulationshindrande komposition (Anticoagulant Composition)
SE0300207D0 (sv)	2003-01-29	2003-01-29	Karolinska Innovations Ab	New use and composition
US20050058671A1 (en) *	2003-05-09	2005-03-17	Bedding Peter M.J.	Dietary supplement and method for treating digestive system-related disorders
US7658964B2 (en) *	2003-05-09	2010-02-09	Freedom Health, Llc	Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
US7824706B2 (en) *	2003-05-09	2010-11-02	Freedom Health, Llc	Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7988989B2 (en) *	2003-05-09	2011-08-02	Freedom Health, Llc	Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
DE10336841A1 (de) *	2003-08-11	2005-03-17	Rovi Gmbh & Co. Kosmetische Rohstoffe Kg	Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
ES2258694T3 (es)	2003-11-11	2006-09-01	Mattern, Udo	Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
US8784869B2 (en)	2003-11-11	2014-07-22	Mattern Pharma Ag	Controlled release delivery system for nasal applications and methods of treatment
JP4994039B2 (ja) *	2003-11-26	2012-08-08	スパーナスファーマシューティカルズインコーポレイテッド	脂溶性または疎水性化合物の送達に有用なミセル系
CA2593956A1 (en)	2004-12-22	2006-06-29	Lipopeptide Ab	Agents inhibiting the cathelin-like protein cap18/ll-37
ATE554656T1 (de) *	2005-03-04	2012-05-15	Dsm Ip Assets Bv	Teilchenförmige nahrungsmittel-lipid- zusammensetzung
DE102005023640A1 (de) *	2005-05-19	2006-11-23	Beiersdorf Ag	Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
DE102005023636A1 (de) *	2005-05-19	2006-11-23	Beiersdorf Ag	Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023638A1 (de) *	2005-05-19	2006-11-23	Beiersdorf Ag	Kosmetische Zubereitungen mit einem Gehalt an Glucosylglyceriden und einem oder mehreren Acrylamidomethylpropylsulfonsäure-Polymeren
EA012422B1 (ru) *	2005-09-16	2009-10-30	ДСМ АйПи АССЕТС Б.В.	Фармацевтическая липидная композиция в виде частиц
PL2068825T3 (pl)	2006-10-04	2011-06-30	M & P Patent Ag	Układ dostarczania o kontrolowanym uwalnianiu do donosowego podawania związków neuroprzekaźnikowych
EP2174646B1 (en) *	2007-08-09	2019-05-22	Kao Corporation	Reverse vesicle
US20090137497A1 (en) *	2007-11-23	2009-05-28	Beiersdorf Ag	Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
US20090285869A1 (en) *	2008-05-14	2009-11-19	Humco Holding Group, Inc.	Salt stable lecithin organogel composition
JP2010104946A (ja) *	2008-10-31	2010-05-13	Riso Kagaku Corp	逆ベシクルを用いて形成された油中水（ｗ／ｏ）型エマルション
CN101787059B (zh) *	2009-05-12	2014-10-15	沈阳药科大学	双半乳糖基二酰甘油酯的制备方法及其应用
ES2548681T3 (es) *	2010-03-24	2015-10-20	Medesis Pharma	Sistema micelar inverso que comprende iones metálicos y uso del mismo
NO2575768T3 (pl) *	2010-05-24	2018-05-12
EP2389816A1 (en)	2010-05-25	2011-11-30	Nestec S.A.	Synergistic antioxidant composition
AR086400A1 (es)	2011-05-13	2013-12-11	Trimel Pharmaceuticals Corp	Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en)	2011-05-13	2013-02-21	Trimel Pharmaceuticals Corporation	Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en)	2011-05-13	2017-09-12	Acerus Pharmaceuticals Srl	Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
JP6239822B2 (ja) *	2012-12-27	2017-11-29	ポーラ化成工業株式会社	逆ベシクル組成物
JP6242582B2 (ja) *	2013-04-01	2017-12-06	ポーラ化成工業株式会社	逆ベシクル組成物の製造方法
JP6334151B2 (ja) *	2012-12-25	2018-05-30	ポーラ化成工業株式会社	逆ベシクル組成物
WO2014103742A1 (ja) *	2012-12-25	2014-07-03	ポーラ化成工業株式会社	逆ベシクル組成物及びその製造方法
JP6242581B2 (ja) *	2013-04-01	2017-12-06	ポーラ化成工業株式会社	逆ベシクル組成物の製造方法
US11744838B2 (en)	2013-03-15	2023-09-05	Acerus Biopharma Inc.	Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
ES2669614T3 (es) *	2013-04-16	2018-05-28	Dow Global Technologies Llc	Masa y pastel estratificado de bajo contenido en grasa
WO2020237383A1 (en) *	2019-05-31	2020-12-03	Groupe Santé Devonian Inc.	Thylakoids as delivery system for cannabinoïds and other molecules and formulations thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0009842B1 (en) *	1978-10-02	1982-11-10	THE PROCTER & GAMBLE COMPANY	Liposomes for drug delivery and composition containing a liposome drug system
SE8206744D0 (sv) *	1982-11-26	1982-11-26	Fluidcarbon International Ab	Preparat for kontrollerad avgivning av substanser
US4610868A (en) *	1984-03-20	1986-09-09	The Liposome Company, Inc.	Lipid matrix carriers for use in drug delivery systems
DE3778972D1 (de) *	1986-06-12	1992-06-17	Liposome Co Inc	Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
US5234767A (en) *	1987-03-13	1993-08-10	Micro-Pak, Inc.	Hybrid paucilamellar lipid vesicles
SE9003100D0 (sv) *	1990-09-28	1990-09-28	Kabivitrum Ab	Lipid formulation system
JP2774429B2 (ja) *	1992-03-17	1998-07-09	株式会社ディ・ディ・エス研究所	糖骨格を有する分枝鎖型誘導体

1995
- 1995-02-06 NZ NZ279954A patent/NZ279954A/en unknown
- 1995-02-06 AU AU17235/95A patent/AU691250B2/en not_active Ceased
- 1995-02-06 HU HU9602142A patent/HU221432B/hu not_active IP Right Cessation
- 1995-02-06 KR KR1019960704239A patent/KR100220546B1/ko not_active IP Right Cessation
- 1995-02-06 US US08/676,137 patent/US5716639A/en not_active Expired - Lifetime
- 1995-02-06 CA CA002182577A patent/CA2182577C/en not_active Expired - Fee Related
- 1995-02-06 JP JP52055795A patent/JP3203359B2/ja not_active Expired - Lifetime
- 1995-02-06 DE DE69521300T patent/DE69521300T2/de not_active Expired - Lifetime
- 1995-02-06 WO PCT/SE1995/000117 patent/WO1995020945A1/en active IP Right Grant
- 1995-02-06 AT AT95909185T patent/ATE201980T1/de not_active IP Right Cessation
- 1995-02-06 CN CN95191484A patent/CN1091591C/zh not_active Expired - Fee Related
- 1995-02-06 ES ES95909185T patent/ES2158084T3/es not_active Expired - Lifetime
- 1995-02-06 DK DK95909185T patent/DK0743851T3/da active
- 1995-02-06 EP EP95909185A patent/EP0743851B1/en not_active Expired - Lifetime
- 1995-02-06 PL PL95315780A patent/PL178394B1/pl not_active IP Right Cessation
- 1995-02-09 MY MYPI95000299A patent/MY112435A/en unknown
- 1995-02-13 TW TW084101256A patent/TW482685B/zh not_active IP Right Cessation
1996
- 1996-08-02 NO NO19963242A patent/NO312495B1/no not_active IP Right Cessation
- 1996-08-02 FI FI963066A patent/FI963066A/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1140405A (zh)	1997-01-15
AU691250B2 (en)	1998-05-14
FI963066A (fi)	1996-09-30
HUT75470A (en)	1997-05-28
DK0743851T3 (da)	2001-09-03
DE69521300T2 (de)	2002-05-02
ES2158084T3 (es)	2001-09-01
ATE201980T1 (de)	2001-06-15
HU9602142D0 (en)	1996-09-30
CN1091591C (zh)	2002-10-02
JP3203359B2 (ja)	2001-08-27
NO963242L (no)	1996-08-02
NO963242D0 (no)	1996-08-02
FI963066A0 (fi)	1996-08-02
CA2182577A1 (en)	1995-08-10
EP0743851A1 (en)	1996-11-27
KR100220546B1 (ko)	1999-09-15
TW482685B (en)	2002-04-11
DE69521300D1 (de)	2001-07-19
CA2182577C (en)	2002-08-20
US5716639A (en)	1998-02-10
PL315780A1 (en)	1996-12-09
WO1995020945A1 (en)	1995-08-10
MY112435A (en)	2001-06-30
AU1723595A (en)	1995-08-21
JPH09508415A (ja)	1997-08-26
HU221432B (en)	2002-10-28
PL178394B1 (pl)	2000-04-28
NZ279954A (en)	1998-02-26
EP0743851B1 (en)	2001-06-13

Publication	Publication Date	Title
NO312495B1 (no)	2002-05-21	Lipofile b¶rerpreparat, anvendelse derav som b¶rer, samt farmasöytisk blanding omfattende lipofilt b¶rerpreparat oganvendelse av et galaktolipidmateriale for fremstilling av etlipofilt b¶rerpreparat, og omvendte vesikler
US5688528A (en)	1997-11-18	Oil-in water emulsions
EP0744939B1 (en)	2002-09-25	Bilayer preparations made from digalactosyldiacylglycerol containing galactolipid
US6355693B1 (en)	2002-03-12	Fractionated vegetable oil
JPH06279467A (ja)	1994-10-04	リン脂質組成物
RU2127124C1 (ru)	1999-03-10	Препараты липофильных носителей
RU2131266C1 (ru)	1999-06-10	Эмульсия типа "масло в воде", носитель на ее основе и фармацевтическая композиция
MXPA96003038A (en)	1998-01-01	Oil emulsions in a

Legal Events

Date	Code	Title	Description
2005-10-10	MM1K	Lapsed by not paying the annual fees